AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Eveglim-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Eleveton Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Eveglim-M1 Tablet SR

Diabexe Duo SR tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy effectively manages blood glucose levels. Diabexe Duo SR should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled glucose levels; abrupt cessation can lead to dangerously elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle modifications are crucial for successful diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremor) and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential preventative steps. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Eveglim-M1 Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Eveglim-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Eveglim-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Eveglim-M1 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Eveglim-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Eveglim-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Eveglim-M1 Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Eveglim-M1 Tablet SR works:

Eveglim-M1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, inhibiting intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eveglim-M1 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Eveglim-M1 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Eveglim-M1 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Eveglim-M1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Eveglim-M1 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Eveglim-M1 Tablet SR :

Should you forget a dose of Eveglim-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Eveglim-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Eveglim-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Eveglim-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Eveglim-M1 Tablet SR and seek immediate medical attention.
Eveglim-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Eveglim-M1 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Eveglim-M1 Tablet SR can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Yes, Eveglim-M1 Tablet SR can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Eveglim-M1 Tablet SR and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Eveglim-M1 Tablet SR
29
MRP 35
17% off